Biomedical Research Council
Established in October 2000, the Biomedical Research Council (BMRC) supports, oversees and coordinates public sector biomedical research and development activities in Singapore. BMRC:
- oversees the development of core research capabilities within A*STAR research units specialising in bioprocessing; genomics and proteomics; molecular and cell biology; bioengineering and nanotechnology; and computational biology
- actively promotes translational medicine and cross-disciplinary research, as part of its efforts to advance human healthcare
- supports biomedical research in the wider scientific community such as public universities and hospitals
- engages in human capital development in the biomedical sciences and promotes societal awareness of biomedical research through outreach programmes.
BMRC works in close partnership with the Singapore Economic Development Board’s (EDB) Biomedical Sciences Group and Bio*One Capital, in spearheading the Biomedical Sciences (BMS) Initiative to develop Singapore into the Biopolis of Asia – an international biomedical sciences hub that advances human healthcare through the pursuit of excellence in research and development, manufacturing, and healthcare delivery.
BMRC has also been working closely with the Ministry of Health’s (MOH) National Medical Research Council (NMRC) in the second phase of biomedical research which focuses on strengthening capabilities in translational and clinical research.
Underlining this long term aim to be among the most research intensive, innovative and entrepreneurial economies in the world, the overall focus for BMS Phase 3 (from 2011 - 2015) is the greater integration of activities across the entire BMS community, including public and private sector performers, hospitals and government agencies. This would lead to achieving our Research, Innovation & Enterprise (RIE) 2015 vision to transform Singapore's Biomedical Science cluster by drawing on its unique strengths and differentiating advantages to generate economic impact and innovative healthcare solutions.
 |
Singapore identified biomedical sciences as the 4th pillar of our economy in 2000.
|
 |
BMRC oversees research institutes & consortia that support key BMS industry clusters: pharmaceuticals, medical technology, biotechnology and healthcare services.
|
| |
|
|
|
 |
A*STAR provides competitive grant support and research resources to scientists and engineers in its research institutes and other publicly funded institutions in Singapore.
|
 |
Through its partnerships, BMRC aims to promote interactions and collaborations with world-class research entities internationally as well as locally.
|
Back To Top